Pharmafile Logo

DH

- PMLiVE

UKHSA secures UK-based vaccine deal for future influenza pandemics

CSL Sequiris will be ready to produce over 100 million influenza pandemic vaccines

- PMLiVE

Havas Lynx Group launches proprietary data product to drive meaningful change across pharma

Leading global healthcare communications agency, Havas Lynx Group, has launched its proprietary data platform, Point.1, to help pharmaceutical companies to gain a deeper understanding of healthcare professionals (HCPs) to drive...

Havas Lynx

- PMLiVE

CureVac advances ‘promising’ seasonal flu mRNA vaccine to phase 2 development

The mid-stage study of the candidate is expected to begin in the fourth quarter of 2023

- PMLiVE

NHS England to bring forward flu and COVID-19 vaccine programmes

The change follows an announcement on the risks presented by the new BA.2.86 COVID-19 variant

location

Location, Location, Location: The Unseen Star of Your Healthcare Video

In our latest edition of GIG Bites, Jake reveals how the right backdrop can amplify your message and strengthen audience connection.

The Good Ideas Group

- PMLiVE

So, you can deliver excellent outcomes & meaningful impact at low cost

Under the tree: an example of behaviour-change in mental health by fox&cat.

Fox&Cat

- PMLiVE

Whitepaper: Closing the gap with compelling healthcare communications

Want to learn how to close the distance between a person’s current health and their healthiest possible self?

Page & Page and Partners

- PMLiVE

Novavax announces positive phase 2 results for COVID-19/influenza vaccine candidates

A combination COVID-19/influenza vaccine is included in the mid-stage study

- PMLiVE

CureVac announces start of phase 1/2 seasonal influenza vaccine trial

The multivalent mRNA candidates have been developed in collaboration with GSK

- PMLiVE

WHO declares end to COVID-19 global public health emergency

The agency’s emergency committee said it is time to transition to long-term management of the pandemic

- PMLiVE

AMICULUM® collaborates with the University of Dundee to develop a new Master’s course in Science and Health Communication

AMICULUM Limited is proud to announce its collaboration with the University of Dundee in developing a Master’s course in Science and Health Communication. The Master’s course was an idea conceived...

AMICULUM

- PMLiVE

WHO announces launch of new pandemic preparedness initiative

The guidance focuses on respiratory pathogens, including influenza and RSV

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links